Skip to main content

Advertisement

Log in

Association of progressive structural changes in the bronchial epithelium with subepithelial fibrous remodeling: A potential role for hypoxia

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

In airway remodeling that occurs in association with chronic obstructive pulmonary disease (COPD), the relationship between the subepithelium and structural changes of the bronchial epithelium is not well defined. To investigate whether the subepithelium and epithelium undergo remodeling as an integrated unit, we performed morphological examination of 55 bronchial biopsy specimens obtained from explanted or resected lungs from tobacco smokers with COPD. Our results indicate that reticular basement membrane (RBM) thickness is increased and the subepithelial microvascular bed is reduced in association with progression from the normal epithelium to squamous metaplasia. Subsequent bronchial epithelial transformation to dysplasia is characterized by differential subepithelial remodeling with normalization of RBM thickness and subepithelial blood vessel density. Because fibrous remodeling of the subepithelium could limit delivery of nutrients and oxygen to the epithelium, we assessed expression of hypoxia-inducible factor-1α (HIF-1α) and carbonic anhydrase IX (CA IX) as markers of cellular hypoxia. The number of HIF-1α-positive epithelial cells increased with progression of epithelial structural changes, RBM thickness, and reduction in blood vessels in the subepithelium. These findings suggest that the HIF-1α pathway is activated in response to subepithelial remodeling and contributes to progressive premalignant epithelial lesions in the airways of tobacco smokers with chronic airway inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Arsham AM, Plas DR, Thompson CB, Simon MC (2002) Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1 alpha nor sufficient for HIF-1-dependent target gene transcription. J Biol Chem 277:15162–15170

    Article  PubMed  CAS  Google Scholar 

  2. Bardos JI, Ashcroft M (2005) Negative and positive regulation of HIF-1: a complex network. Biochim Biophys Acta 1755:107–120

    PubMed  CAS  Google Scholar 

  3. Bindra RS, Glazer PM (2005) Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis. Mutat Res 569:75–85

    PubMed  CAS  Google Scholar 

  4. Breuer RH, Pasic A, Smit EF, van Vliet E, Vonk NA, Risse EJ, Postmus PE, Sutedja TG (2005) The natural course of preneoplastic lesions in bronchial epithelium. Clin Cancer Res 11:537–543

    PubMed  CAS  Google Scholar 

  5. Breuer RH, Postmus PE, Smit EF (2005) Molecular pathology of non-small-cell lung cancer. Respiration 72:313–330

    Article  PubMed  CAS  Google Scholar 

  6. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867

    Article  PubMed  CAS  Google Scholar 

  7. Cummins EP, Taylor CT (2005) Hypoxia-responsive transcription factors. Pflugers Arch 450:363–371

    Article  PubMed  CAS  Google Scholar 

  8. de Boer WI, Hau CM, van Schadewijk A, Stolk J, van Krieken JH, Hiemstra PS (2006) Expression of epidermal growth factors and their receptors in the bronchial epithelium of subjects with chronic obstructive pulmonary disease. Am J Clin Pathol 125:184–192

    Article  PubMed  Google Scholar 

  9. Dery MA, Michaud MD, Richard DE (2005) Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 37:535–540

    Article  PubMed  CAS  Google Scholar 

  10. Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25:581–611

    Article  PubMed  CAS  Google Scholar 

  11. Forgacs E, Zochbauer-Muller S, Olah E, Minna JD (2001) Molecular genetic abnormalities in the pathogenesis of human lung cancer. Pathol Oncol Res 7:6–13

    Article  PubMed  CAS  Google Scholar 

  12. Galateau-Salle FB, Luna RE, Horiba K, Sheppard MN, Hayashi T, Fleming MV, Colby TV, Bennett W, Harris CC, Stetler-Stevenson WG, Liotta L, Ferrans VJ, Travis WD (2000) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions. Hum Pathol 31:296–305

    Article  PubMed  CAS  Google Scholar 

  13. Greenberg AK, Yee H, Rom WN (2002) Preneoplastic lesions of the lung. Respir Res 3:20

    Article  PubMed  Google Scholar 

  14. Greijer AE, van der GP, Kemming D, Shvarts A, Semenza GL, Meijer GA, van de Wiel MA, Belien JA, van Diest PJ, van der WE (2005) Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol 206:291–304

    Article  PubMed  CAS  Google Scholar 

  15. Haddad JJ, Harb HL (2005) Cytokines and the regulation of hypoxia-inducible factor (HIF)-1alpha. Int Immunopharmacol 5:461–483

    Article  PubMed  CAS  Google Scholar 

  16. Haugland HK, Vukovic V, Pintilie M, Fyles AW, Milosevic M, Hill RP, Hedley DW (2002) Expression of hypoxia-inducible factor-1alpha in cervical carcinomas: correlation with tumor oxygenation. Int J Radiat Oncol Biol Phys 53:854–861

    Article  PubMed  CAS  Google Scholar 

  17. Hirsch FR, Merrick DT, Franklin WA (2002) Role of biomarkers for early detection of lung cancer and chemoprevention. Eur Respir J 19:1151–1158

    Article  PubMed  CAS  Google Scholar 

  18. Hofseth LJ, Ying L (2006) Identifying and defusing weapons of mass inflammation in carcinogenesis. Biochim Biophys Acta 1765:74–84

    PubMed  CAS  Google Scholar 

  19. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350:2645–2653

    Article  PubMed  CAS  Google Scholar 

  20. Jeanmart M, Lantuejoul S, Fievet F, Moro D, Sturm N, Brambilla C, Brambilla E (2003) Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer. Clin Cancer Res 9:2195–2203

    PubMed  CAS  Google Scholar 

  21. Jeffery PK (2001) Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 164:S28–S38

    PubMed  CAS  Google Scholar 

  22. Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749–759

    Article  PubMed  CAS  Google Scholar 

  23. Kerr KM (2001) Pulmonary preinvasive neoplasia. J Clin Pathol 54:257–271

    Article  PubMed  CAS  Google Scholar 

  24. Kietzmann T, Krones-Herzig A, Jungermann K (2002) Signaling cross-talk between hypoxia and glucose via hypoxia-inducible factor 1 and glucose response elements. Biochem Pharmacol 64:903–911

    Article  PubMed  CAS  Google Scholar 

  25. Kim SJ, Rabbani ZN, Dewhirst MW, Vujaskovic Z, Vollmer RT, Schreiber EG, Oosterwijk E, Kelley MJ (2005) Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer. Lung Cancer 49:325–335

    Article  PubMed  Google Scholar 

  26. Knight DA, Holgate ST (2003) The airway epithelium: structural and functional properties in health and disease. Respirology 8:432–446

    Article  PubMed  Google Scholar 

  27. Lantuejoul S, Constantin B, Drabkin H, Brambilla C, Roche J, Brambilla E (2003) Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines. J Pathol 200:336–347

    Article  PubMed  CAS  Google Scholar 

  28. Lawson WE, Polosukhin VV, Stathopoulos GT, Zoia O, Han W, Lane KB, Li B, Donnelly EF, Holburn GE, Lewis KG, Collins RD, Hull WM, Glasser SW, Whitsett JA, Blackwell TS (2005) Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin. Am J Pathol 167:1267–1277

    PubMed  CAS  Google Scholar 

  29. Lawson WE, Polosukhin VV, Zoia O, Stathopoulos GT, Han W, Plieth D, Loyd JE, Neilson EG, Blackwell TS (2005) Characterization of fibroblast-specific protein 1 in pulmonary fibrosis. Am J Respir Crit Care Med 171:899–907

    Article  PubMed  Google Scholar 

  30. Lu H, Ouyang W, Huang C (2006) Inflammation, a key event in cancer development. Mol Cancer Res 4:221–233

    Article  PubMed  CAS  Google Scholar 

  31. Massion PP, Carbone DP (2003) The molecular basis of lung cancer: molecular abnormalities and therapeutic implications. Respir Res 4:12

    Article  PubMed  Google Scholar 

  32. McColl BK, Stacker SA, Achen MG (2004) Molecular regulation of the VEGF family—inducers of angiogenesis and lymphangiogenesis. APMIS Acta Pathol Microbial Immunol Scand 112:463–480

    CAS  Google Scholar 

  33. Merrick DT, Haney J, Petrunich S, Sugita M, Miller YE, Keith RL, Kennedy TC, Franklin WA (2005) Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysis. Lung Cancer 48:31–45

    Article  PubMed  Google Scholar 

  34. Moro-Sibilot D, Fievet F, Jeanmart M, Lantuejoul S, Arbib F, Laverribre MH, Brambilla E, Brambilla C (2004) Clinical prognostic indicators of high-grade pre-invasive bronchial lesions. Eur Respir J 24:24–29

    Article  PubMed  CAS  Google Scholar 

  35. Munoz-Najar UM, Neurath KM, Vumbaca F, Claffey KP (2006) Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation. Oncogene 25:2379–2392

    Article  PubMed  CAS  Google Scholar 

  36. Papi A, Casoni G, Caramori G, Guzzinati I, Boschetto P, Ravenna F, Calia N, Petruzzelli S, Corbetta L, Cavallesco G, Forini E, Saetta M, Ciaccia A, Fabbri LM (2004) COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma. Thorax 59:679–681

    Article  PubMed  CAS  Google Scholar 

  37. Peters EJ, Morice R, Benner SE, Lippman S, Lukeman J, Lee JS, Ro JY, Hong WK (1993) Squamous metaplasia of the bronchial mucosa and its relationship to smoking. Chest 103:1429–1432

    PubMed  CAS  Google Scholar 

  38. Polosukhin VV (2001) Ultrastructure of the bronchial epithelium in chronic inflammation. Ultrastruct Pathol 25:119–128

    Article  PubMed  CAS  Google Scholar 

  39. Postma DS, Timens W (2006) Remodeling in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 3:434–439

    Article  PubMed  CAS  Google Scholar 

  40. Rollins BJ (2006) Inflammatory chemokines in cancer growth and progression. Eur J Cancer 42:760–767

    Article  PubMed  CAS  Google Scholar 

  41. Sacco O, Silvestri M, Sabatini F, Sale R, Defilippi AC, Rossi GA (2004) Epithelial cells and fibroblasts: structural repair and remodelling in the airways. Paediatr Respir Rev 5(Suppl A):S35–S40

    PubMed  Google Scholar 

  42. Schwartz AG, Ruckdeschel JC (2006) Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173:16–22

    Article  PubMed  CAS  Google Scholar 

  43. Semenza GL (2004) Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 19:176–182

    CAS  Google Scholar 

  44. Swinson DE, Jones JL, Cox G, Richardson D, Harris AL, O’Byrne KJ (2004) Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways. Int J Cancer 111:43–50

    Article  PubMed  CAS  Google Scholar 

  45. Swinson DE, Jones JL, Richardson D, Wykoff C, Turley H, Pastorek J, Taub N, Harris AL, O’Byrne KJ (2003) Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J Clin Oncol 21:473–482

    Article  PubMed  CAS  Google Scholar 

  46. Swinson DE, O’Byrne KJ (2006) Interactions between hypoxia and epidermal growth factor receptor in non-small-cell lung cancer. Clin Lung Cancer 7:250–256

    Article  PubMed  CAS  Google Scholar 

  47. Vordermark D, Kaffer A, Riedl S, Katzer A, Flentje M (2005) Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells. Int J Radiat Oncol Biol Phys 61:1197–1207

    Article  PubMed  CAS  Google Scholar 

  48. Williams KJ, Parker CA, Stratford IJ (2005) Exogenous and endogenous markers of tumour oxygenation status: definitive markers of tumour hypoxia? Adv Exp Med Biol 566:285–294

    Article  PubMed  CAS  Google Scholar 

  49. Wouters EF (2005) Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2:26–33

    Article  PubMed  CAS  Google Scholar 

  50. Zhou J, Brune B (2006) Cytokines and hormones in the regulation of hypoxia inducible factor-1alpha (HIF-1alpha). Cardiovasc Hematol Agents Med Chem 4:189–197

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vasiliy V. Polosukhin.

Additional information

Supported by: HL68121, HL66196, HL85406, ATS Research Grant, Vanderbilt Discovery Grant, and the Francis Family Foundation; WEL is a Parker B. Francis Fellow in Pulmonary Research.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Polosukhin, V.V., Lawson, W.E., Milstone, A.P. et al. Association of progressive structural changes in the bronchial epithelium with subepithelial fibrous remodeling: A potential role for hypoxia. Virchows Arch 451, 793–803 (2007). https://doi.org/10.1007/s00428-007-0469-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-007-0469-5

Keywords

Navigation